The agreement would involve a two-year extension of federal payments to insurers that Trump halted last week, said Sen. Lamar Alexander, R-Tenn. Unless the money is quickly restored, insurers and others say that will result in higher premiums for people buying individual policies and in some carriers leaving unprofitable markets
GOP senators’ opposition to their party’s drive to scrap President Barack Obama’s Affordable Care Act swelled to lethal numbers Sunday. Moderate Sen. Susan Collins all but closed the door on supporting the teetering bill and conservative Sen. Ted Cruz said that “right now” he doesn’t back it
“That base is so insistent. You made this promise, stick to it, and you’ll be penalized if you don’t,” said Bill Hoagland, a former top Senate GOP aide and health policy expert.
“Ending the payments to insurers would introduce more chaos into an unsettled market, and perversely end up costing the federal government more in the end,” said Larry Levitt of the Kaiser Family Foundation, a nonpartisan group that found similar results.
That’s the resounding word from a national poll released Friday by the nonpartisan Kaiser Family Foundation. The survey was taken following last month’s Senate derailment of the GOP drive to supplant much of President Barack Obama’s statute with a diminished federal role in health care
The analysis released Thursday by the Kaiser Family Foundation found that mixed signals from President Donald Trump have created uncertainty “far outside the norm,” leading insurers to seek higher premium increases for 2018 than would otherwise have been the case
There’s never been a better time to be treated for a heart attack. U.S. hospitals have set a record for how quickly they open blocked arteries, averaging under one hour for the first time since these results have been tracked. More than 93 percent of patients now have their arteries opened within the recommended 90 […]
“It’s absolutely clear that e-cigarettes help smokers replace cigarettes,” said Peter Hajek, director of the health and lifestyle research unit at Queen Mary University in London, who wasn’t part of the study.
How? It has to do with lifestyle factors that may make the brain more vulnerable to problems with memory and thinking as we get older. They’re such risks as not getting enough education early in life, high blood pressure and obesity in middle age, and being sedentary and socially isolated in the senior years
Johnson & Johnson said that in one patient study, about seven in 10 patients getting the drug, Tremfya, had clear or nearly clear skin after 24 weeks of treatment. That compares with about four in 10 patients receiving rival AbbVie’s Humira, which treats several immune disorders and is the world’s top selling drug.